EVOGENE LTD. Fee And Commission Expense
EVOGENE LTD. (EVGN) reported Fee And Commission Expense of $32.00 thousand for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-26.
Financial Statements › Expense Statement › Operating Expenses
ifrs-full:FeeAndCommissionExpense · last filed 2026-03-26
| Period end | Fee And Commission Expense 12 month | Fee And Commission Expense 12 month as first filed |
|---|---|---|
| 2025-12-31 | $32.00K 20-F · filed 2026-03-26 | |
| 2024-12-31 | $57.00K 20-F · filed 2026-03-26 | $61.00K 20-F · filed 2025-03-27 |
| 2023-12-31 | $48.00K 20-F · filed 2026-03-26 | $56.00K 20-F · filed 2024-03-28 |
| 2022-12-31 | $76.00K 20-F · filed 2025-03-27 | |
| 2021-12-31 | $88.00K 20-F · filed 2024-03-28 | |
| 2020-12-31 | $32.00K 20-F · filed 2023-03-30 | |
| 2019-12-31 | $52.00K 20-F · filed 2022-03-31 | |
| 2018-12-31 | $141.00K 20-F · filed 2021-04-02 | |
| 2017-12-31 | $129.00K 20-F · filed 2020-04-27 | |
| 2016-12-31 | $155.00K 20-F · filed 2019-04-29 | |
| 2015-12-31 | $195.00K 20-F · filed 2018-03-30 |